Research programme - peptide melanocortin receptor 2 antagonists - IpsenAlternative Names: ACTH receptor antagonists - Ipsen; Adrenocorticotropic hormone receptor antagonists - Ipsen; IRC 274; MC2 receptor antagonists - Ipsen
Latest Information Update: 09 Aug 2016
At a glance
- Originator Ipsen
- Class Peptide hormones; Peptides
- Mechanism of Action Melanocortin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pituitary ACTH hypersecretion